ArticleFrontiers in oncology2023

Immune responses and clinical outcomes following the third dose of SARS-CoV-2 mRNA-BNT162b2 vaccine in advanced breast cancer patients receiving targeted therapies: a prospective study.

Fabrizio Nelli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.